In control livers, Cyp2e1 was zonally expressed in pericentral hepatocytes both untreated (-NASH-MSC) and treated with MSCs (-NASH+MSC), which was paralleled by weak zonal detection of 4-HNE. This evidence concerns the gene CYP2E1 and metabolic dysfunction-associated steatohepatitis.